Monitoring Parameters for Sertraline Treatment
Critical Early Monitoring
- The American Academy of Child and Adolescent Psychiatry recommends monitoring closely for emergence of suicidal thoughts and behaviors, particularly during the first 1-2 months of treatment when risk is highest, in patients taking sertraline 1
- The American Academy of Child and Adolescent Psychiatry suggests watching for motor or mental restlessness, insomnia, impulsiveness, talkativeness, disinhibited behavior, and aggression, which are more common in younger children than adolescents and typically occur early in treatment or with dose increases, in patients taking sertraline 2
Serotonin Syndrome Monitoring
- The American Academy of Child and Adolescent Psychiatry recommends monitoring for serotonin syndrome symptoms within 24-48 hours after starting treatment or any dose adjustment, especially if the patient is taking other serotonergic medications, in patients taking sertraline 2
Ongoing Therapeutic Monitoring
- The American College of Physicians, as reported in the Annals of Internal Medicine, recommends assessing patient status, therapeutic response, and adverse effects regularly beginning within 1-2 weeks of initiation of sertraline treatment 1
- The American Academy of Child and Adolescent Psychiatry suggests expecting clinically significant improvement by week 6 and maximal improvement by week 12 or later, following a logarithmic response model, in patients taking sertraline 2
- The American College of Physicians, as reported in the Annals of Internal Medicine, recommends modifying treatment if no adequate response occurs within 6-8 weeks, in patients taking sertraline 1
Special Populations and Situations
- The American Academy of Child and Adolescent Psychiatry recommends using sertraline cautiously in patients with a history of seizure disorder, as seizures have been observed with SSRI use, including sertraline 2
- The American Academy of Child and Adolescent Psychiatry suggests distinguishing between behavioral activation (occurs early, improves quickly with dose reduction) and mania/hypomania (appears later, persists, requires active intervention) in patients taking sertraline 2
Common Pitfalls to Avoid
- The American Academy of Child and Adolescent Psychiatry recommends never abruptly discontinuing sertraline—taper gradually to avoid discontinuation syndrome, in patients taking sertraline 3